113 related articles for article (PubMed ID: 1544846)
1. The effect of hypoxia and low pH on the cytotoxicity of chlorambucil.
Skarsgard LD; Chaplin DJ; Wilson DJ; Skwarchuk MW; Vinczan A; Kristl J
Int J Radiat Oncol Biol Phys; 1992; 22(4):737-41. PubMed ID: 1544846
[TBL] [Abstract][Full Text] [Related]
2. The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake.
Skarsgard LD; Skwarchuk MW; Vinczan A; Kristl J; Chaplin DJ
Anticancer Res; 1995; 15(1):219-23. PubMed ID: 7733636
[TBL] [Abstract][Full Text] [Related]
3. Extracellular pH, transmembrane distribution and cytotoxicity of chlorambucil.
Mikkelsen RB; Asher C; Hicks T
Biochem Pharmacol; 1985 Jul; 34(14):2531-4. PubMed ID: 4015693
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of chlorambucil cytotoxicity by combination with flavone acetic acid in a murine tumour.
Parkins CS; Chadwick JA; Chaplin DJ
Anticancer Res; 1994; 14(4A):1603-8. PubMed ID: 7979193
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride: an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pH.
Hasuda K; Lee C; Tannock IF
Oncol Res; 1994; 6(6):259-68. PubMed ID: 7865901
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs.
Chaplin DJ; Acker B; Olive PL
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1131-5. PubMed ID: 2715058
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intracellular pH control and relationship to cytotoxicity of chlorambucil and vinblastine.
Parkins CS; Chadwick JA; Chaplin DJ
Br J Cancer Suppl; 1996 Jul; 27():S75-7. PubMed ID: 8763851
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and bioreductive potential of a mono N-oxide derivative of the alkylating agent chlorambucil.
Kirkpatrick DL; Schroeder HL; Chandler KJ
Anticancer Drugs; 1994 Aug; 5(4):467-72. PubMed ID: 7949253
[TBL] [Abstract][Full Text] [Related]
9. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics.
Gerweck LE; Vijayappa S; Kozin S
Mol Cancer Ther; 2006 May; 5(5):1275-9. PubMed ID: 16731760
[TBL] [Abstract][Full Text] [Related]
10. Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapy.
Chaplin DJ; Acker BD; Horsman MR
Biomed Biochim Acta; 1989; 48(2-3):S264-8. PubMed ID: 2730621
[TBL] [Abstract][Full Text] [Related]
11. Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapy.
Chaplin DJ
J Natl Cancer Inst; 1989 Apr; 81(8):618-22. PubMed ID: 2704051
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of weak electrolytes after the adaptation of cells to low pH: role of the transmembrane pH gradient.
Kozin SV; Gerweck LE
Br J Cancer; 1998 May; 77(10):1580-5. PubMed ID: 9635832
[TBL] [Abstract][Full Text] [Related]
13. The effect of the drug lonidamine on Chinese hamster ovary cells in vitro and on experimental tumors.
Rotin D; Tannock IF
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1595-8. PubMed ID: 6480446
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
Br J Cancer; ; . PubMed ID: 10070871
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
